Skip to main content

Currently Skimming:

Vaccines
Pages 267-324

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 267...
... Concerns prior to the Gulf War regarding Iraq's offensive biological warfare capabilities, led to decisions that available vaccines should be utilized as preventive measures against biological warfare agents. It is estimated that 310,680 doses of the anthrax vaccine licensed by the Food and Drug Administration (FDA)
From page 268...
... This chapter discusses several vaccine-related issues that have been of particular concern to Gulf War veterans. The chapter discusses animal and human studies that have been conducted on the safety of the anthrax vaccine and the botulinum toxoid vaccine.
From page 269...
... . Studies on the botulinum toxoid and anthrax vaccines have relied primarily on passive surveillance approaches and have involved only relatively short periods of follow-up.
From page 270...
... · Multiple vaccinations. Individuals often receive several vaccines at a time or over a short period, which makes it difficult to identify the culprit vaccine in the event of an adverse effect.
From page 271...
... Thus, even careful and extensive earlier studies may not be generalizable to current experience. Difficulties in Detecting Adverse Events Due to Vaccinations in Animals Focus on Vaccine Efficacy Most animal studies focus on the efficacy of the vaccine and do not examine adverse effects.
From page 272...
... Animal studies have limitations in detecting adverse effects due to Types II through IV hypersensitivity because the time course of such responses may involve months or years to become clinically apparent in an animal, which is beyond the time frame monitored in most animal studies. Genetic inheritance strongly influences the immune response, both to immunization and to actual infection (Box 7.1)
From page 274...
... as a stabilizer (BioPort, 1999; Friedlander et al., 1999~. 4During the Gulf War, British troops received the U.K.
From page 275...
... Toxicology Anthrax disease results from exposure to the bacterium Bacillus anthracis through three primary routes: cutaneous, inhalation, and gastrointestinal. Regardless of the route of exposure, the presence of the organism provokes an immune response.
From page 276...
... Live spore vaccines induce a humoral immune response. However, the live spore vaccine also elicits a cell-mediated immune response (Shlyakhov and Rubinstein, 1994b)
From page 277...
... Animal Studies As noted earlier in this chapter, adverse health outcomes in animals after injection may result from the toxic effects of the injected substances or from stimulation of the immune system. Injection of the live spore vaccine can cause infection.
From page 278...
... Guinea pigs vaccinated with the live spore vaccine have delayed-type hypersensitivity reactions 1 year after vaccination (Shlyakhov, 1970; Shlyakhov and Rubinstein, 1994b) , indicating stimulation of the cellular immune response.
From page 279...
... Most studies in laboratory animals with the protective antigen vaccine have not mentioned adverse effects associated with vaccination. Many studies conducted in guinea pigs employed different vaccination regimens using culture filtrates of PA with and without alum adjuvant.
From page 280...
... Conclusions on Animal Studies Few meaningful conclusions for humans can be drawn from animal studies of the anthrax vaccine. Many of the animal studies have used the anthrax live spore vaccine and therefore, have limited applicability for evaluating the toxicity of protective antigen vaccines.
From page 281...
... . There was an increase in the number of persons experiencing pain after the second dose, and local reactions 5The one live spore vaccine study that met the Cochrane criteria was a field trial conducted by Burgasov and colleagues.
From page 282...
... Although the vaccine used in this study was similar to the current vaccine (used to immunize Gulf War troops and currently available in the United States) in that it was a PA vaccine, the manufacturing process has since changed and a different strain of anthrax bacillus is now used (GAO, l 999c)
From page 283...
... , mild local reactions (<3 cm) occurred in 3-20 percent of all doses, moderate local reactions (>3 to <12 cm)
From page 284...
... As described earlier in this chapter, the Vaccine Adverse Event Reporting System is a passive surveillance system consisting of reports filed by health care providers, individuals receiving vaccinations, family members, or others. As noted earlier, VAERS data are useful as a sentinel for adverse events but are limited in their usefulness for assessing the rate of adverse events since underreporting is likely and the information may be incomplete or duplicative, or may not always have been confirmed by medical personnel (IOM, 1994~.
From page 285...
... of either the anthrax or the botulinum toxoid vaccine, or both, depending on what they had received in 1990-1991. The report states that there was daily monitoring for systemic and local reactions but does not state the total duration of follow-up.
From page 286...
... The committee located only one randomized peer-reviewed study of the type of anthrax vaccine used in the United States (Brachman et al., 1962~. However, the formulation of the vaccine used in that study differs somewhat from the vaccine given to Gulf War veterans (and currently in use)
From page 287...
... The committee concludes that there is sufficient evidence of an association between anthrax vaccination and transient acute local and systemic effects (e.g., redness, swelling, fever) typically associated with vaccination.
From page 288...
... Additionally, it is estimated that 8,000 U.S. troops received the toxoid during the Gulf War.
From page 289...
... After exposure to formaldehyde they are tested for toxicity in mice and guinea pigs to ensure that the neurotoxin was inactivated. Animal Studies As noted earlier in this chapter, adverse health outcomes can result either from toxic effects of the injected toxoid preparation or from stimulation of the immune system.
From page 290...
... In none of these studies did the authors mention adverse effects, which may indicate that no adverse effects occurred, that adverse events were not monitored, or that the adverse events were not sufficiently severe to warrant termination of the experiment. Studies in guinea pigs suggest that skin-sensitizing anaphylactic antibodies may be produced in response to the administration of a combination of type B botulinum toxoid with the complex typhoid antigen (Yefremova, 1980~.
From page 291...
... Subsequent experiments used purified neurotoxin fragments, and no toxicity occurred after repeated vaccination of these recombinant preparations. Conclusions on Animal Studies Animal studies using botulinum toxoid vaccines have reported minimal transient local reactions and swelling at the injection site.
From page 292...
... , and the authors stated that the incidence of mild local reaction was somewhat greater for the pentavalent toxoids than the control group toxoids (Flock et al., 1962~. Other Studies and Reports The committee received reports on several other studies, discussed below, with information on the botulinum toxoid vaccine.
From page 293...
... Summary tables in the CDC report record the number of reactions for the 16,676 injections of the botulinum toxoid administered between 1970 and 1997 (CDC, 1998~. Ofthis total, local reactions were characterized as 15,207 (91.2 percent)
From page 294...
... MULTIPLE VACCINATIONS Military personnel often receive several vaccinations as they prepare for service in an environment with many endemic diseases. People have been expressed concerns that multiple vaccinations prior to and during Gulf War service may have caused adverse health effects.
From page 295...
... These guidelines are similar to civilian guidelines developed by the CDC and the Advisory Committee on Immunization Practices (IOM, 1996~. Combining several vaccines into a single injection or administering multiple vaccinations at the same clinical visit decreases the number of injections re
From page 296...
... reports that described a set of specific adverse effects remained constant compared to the frequency reported for separate administrations, with one exception: local reactions were more frequent with simultaneous vaccinations (Chen et al., 19951. The MSAEFI system was a passive surveillance system based on reports by people who had been vaccinated, family members, and other individuals.
From page 297...
... found that simultaneous injections of live vaccines for anthrax, plague, tularemia, and brucellosis in guinea pigs reduced the development of protective immunity to anthrax without adversely affecting the response to the other live vaccines. The only adverse effect of the vaccination itself was erythema and an infiltrate at the site of injection of the live spore anthrax vaccine, a response that resolved within 3 to 5 days.
From page 298...
... Good protection was afforded to all antigens, and the authors did not mention any adverse effects. In guinea pigs, a comparative study was done to assess the efficacy of a protective antigen anthrax vaccine, either alone or in combination with a pertussis vaccine (Turnbull, 1990~.
From page 299...
... The second group of studies followed laboratory workers at Fort Detrick who received an intensive vaccination program for occupational reasons. Further, the committee examined several studies of Gulf War veterans.
From page 300...
... Study results suggest that transient RF and IC reactions may be related to the immune response to intensive vaccination. However, the number of subjects with positive results was small, and no control group was used to test for spontaneous fluctuations in RF response.
From page 301...
... who had not undergone multiple vaccinations served as the control group for the electrophoretic studies (controls were not done for the other tests)
From page 302...
... The vaccination program was discontinued 10 months before this study. As in the previous studies, each subject underwent a complete medical history, physical examination, electrocardiogram, and extensive laboratory tests.
From page 303...
... Gulf War Veterans Several studies of Gulf War veterans have looked for associations between health outcomes and exposure to a variety of agents, including vaccinations. The methodology and general results of these studies are described in Chapter 2.
From page 304...
... The total number of vaccinations received bore a weak but significant relationship to the occurrence of the multisymptom outcome among all Gulf War veterans, even when the cohort was subdivided into groups according to whether the subject possessed his vaccination records or not. The association still existed after controlling for the receipt of biological warfare vaccines and for experiencing side effects after vaccination (although the addition of this independent variable weakened the association)
From page 305...
... , Fukuda and colleagues (1998) performed clinical evaluations on a group of Gulf War veterans (n = 158)
From page 306...
... The U.K. Gulf War studies provide some limited evidence of an association between multiple vaccinations and long-term multisymptom outcomes, particularly for vaccinations given during deployment (Unwin et al., 1999; Hotopf et al., 2000~.
From page 307...
... report found that at the time of the Gulf War, DoD had concerns about having a sufficient quantity of the anthrax vaccine and suff~cient time to fully immunize the troops (GAO, 1999a)
From page 308...
... Animal Studies There are few published studies of squalene toxicity in animals or humans (Kelly, 1999~. Kamimura and colleagues (1989)
From page 309...
... Although the mechanisms are not fully understood, the inflammation is blocked by agents that suppress T cells (Yoshino, 1996; Sverdrup et al., 1998~. Animal studies do not report whether injection of squalene produces antisqualene antibodies.
From page 310...
... MTP-PE was associated with moderate to severe local reactions as well as with self-limited severe systemic reactions that resolved within 2-3 days. The same vaccines in the MF59 emulsion alone were well tolerated (Keefer et al., 1996~.
From page 311...
... Sample sizes were small, and the study may suffer from misclassification errors since the group of Gulf War veterans categorized as healthy (n = 12) was not devoid of individuals with serious symptoms (1 had fibromyalgia, 1 had thyroid disease, 3 had memory loss, and 4 had chronic fatigue)
From page 312...
... The committee located only one randomized peer-reviewed study of the type of anthrax vaccine used in the United States (Brachman et al., 19624. However, the formulation of the vaccine used in that study differs somewhat from the vaccine given to Gulf War veterans (and currently in use)
From page 313...
... Botulinum Toxoid Studies have noted transient local and systemic effects of the botulinum toxoid vaccine. However, studies of the botulinum toxoid vaccine have not used active surveillance to systematically evaluate long-term health outcomes.
From page 314...
... The U.K. Gulf War studies provide some limited evidence of an association between multiple vaccinations and long-term multisymptom outcomes, particularly for vaccinations given during deployment (Unwin et al., 1999; Hotopf et al., 2000~.
From page 315...
... 2000. Antibodies to squalene in Gulf War syndrome.
From page 316...
... 1998. Report of the Special Investigation Unit on Gulf War Illnesses.
From page 317...
... 1998. Chronic multisymptom illness affecting Air Force veterans of the Gulf War.
From page 318...
... 1999a. Gulf War mnesses: Questions About the Presence of Squalene Antibodies in Veterans Can Be Resolved.
From page 319...
... 1995. Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs.
From page 320...
... II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine.
From page 321...
... 1986. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
From page 322...
... 1997. Gulf War syndrome: Is it due to a systemic shift in cytokine balance towards a Th2 profile?
From page 323...
... 1986. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
From page 324...
... 1999. Health of UK servicemen who served in Persian Gulf War.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.